The 2011 versions of these commerical agreements include two changes from older versions:

• The new definition of 'agent' makes it clear that in the context of clinical trials and clinical investigations, universities are 'agents' of the NHS body that enters into the clinical trial or clinical investigation agreement with the sponsor. 
  
• The modified clause 3.5 states that either party to a bipartite agreement (sponsor or NHS body), or any party in the case of CRO-managed trials and investigations, can terminate the agreement in the event that the other party (or any other party in the case of the CRO-managed studies) commits any offence covered by the Bribery Act 2010, in relation to the agreement or the clinical study.